Patented Medicine Price Review Board hearings show public pharmacare is the strongest option
Tag: Pharmacare
All Troy Media editorial content that pertains to implementing a Pharmacare program in Canada.
Ottawa needs to reset its relationship with drug developers
Politicians have to stop creating impediments to access
Poll exposes key problems with a national pharmacare plan
Rather than covering every Canadian for drugs they can already afford, we should focus on those who fall through the cracks
National pharmacare will be very expensive and likely unnecessary
The Trudeau government must exercise prudence and target assistance to Canadians with the greatest need
Canada can learn from Swiss and Dutch drug coverage
Both countries partner with the private sector and expect patients to share the cost of treatment
Quebec’s universal prescription drug program offers valuable lessons
Public coverage in Quebec is not only more generous, but drug approval is more timely than anywhere else in the country
Universal pharmacare will cut costs and save lives
When it comes to prescription drug coverage, our health system has plenty in common with the United States – and that’s not a good thing
Steer clear of the Big Money Club when crafting national pharmacare
Prescription drug policy in Canada ought to be decided in the interest of Canadians, not based on the power of industry sector lobbies
National pharmacare can hurt patients more than it helps
Will likely result in reduced access to new drugs, and delay research and development
Before implementing national pharmacare, look at what provinces already offer
Instead of using scarce health-care dollars broadly, we should identify and support those Canadians falling through the cracks